Visitors gather at UCB's booth during the fifth China International Import Expo in Shanghai in November 2022. [Photo provided to China Daily] China's commitment to foster innovation and advance ...

Revenue: €12.0m (up 21% from FY 2023). Net loss: €19.4m (loss narrowed by 4.7% from FY 2023). €0.42 loss per share (improved from €0.44 loss in FY 2023). Revenue exceeded analyst estimates ...

Revenue: €12.0m (up 21% from FY 2023). Net loss: €19.4m (loss narrowed by 4.7% from FY 2023). €0.42 loss per share (improved from €0.44 loss in FY 2023). Revenue exceeded analyst estimates by 11%.

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

For decades, America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme (PBS). Twenty years ago, they scored a huge victory when they secured major ...

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than ...

Copyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Purdue Pharma asked a bankruptcy judge ...